Low Health Literacy Prevalence's Study in Patients With Chronic Cardiovascular Disease

NCT03952013 | Withdrawn

• 1 other identifier: LIT-S
• Study Type: observational
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

Health literacy is the ability to access, understand, evaluate and apply information in order to communicate with health professionals and understand health instructions but also, promote, maintain and improve health throughout life. Health literacy (HL) is known as a health determinant. An association has been shown between low HL and poorer health outcomes such as increased number of unscheduled hospitalisation or emergency visits, low medication adherence and poor health status. These have been particularly demonstrated with cardiovascular diseases, which combine risk factors (emergency hospitalization, reduction in the length of hospital stays, and complex secondary preventive drug treatments). Despite large scientific international literature about HL and health outcomes, no information is available in France on the prevalence of low HL level among patients managed for neuro-cardio-vascular diseases. It has been shown in other countries that healthcare professionals overestimate the HL level of their patients and do not adapt information to the HL level. Therefore, patients with low HL do not understand and/or are not able to use properly the information they receive. Having a better knowledge of HL level and characteristics in these patients is necessary to develop tools for helping healthcare professionals to identify patients with low HL level and to realize the role of HL as a determinant of health. It will also provide more precise information on the difficulties or needs of patients with different levels of health literacy.

Conditions

Cardiovascular Diseases

Outcome Measures

Primary Outcomes (1)

• Health literacy levels measured by BHLS

  Health literacy will be measured using the Brief Health Literacy Screening (BHLS) questionnaire. The BHLS is known to screen quickly health literacy with 3 questions corresponding to 3 dimensions of the Health and Labour Questionnaire (HLQ): Enough information to manage health, Ability to actively engage with healthcare providers and Sufficient understanding to know what to do.

  At 2 months after study participation acceptation

Study Arms (1)

Study group

All eligible patients included into one of the three existing cohorts studies of Hospices Civils de Lyon's hospitals: LOOP-HF, HIBISCUS-STEMI and HIBISCUS-STROKE * LOOP-HF (Registry of Congestive Heart Failure, NCT03422991), * HIBISCUS-STEMI (Prospective cohort with a heart attack from ST segment elevation myocardium admitted to the centre coronary angiography room participating investigators, NCT03070496) * HIBISCUS-STROKE (Prospective cohort of Stroke patients, NCT03149705)

Other: To explore health literacy levels in patients hospitalized for acute neuro-cardiovascular diseases i.e. stroke, myocardial infarction, or heart failure

Interventions

To explore health literacy levels in patients hospitalized for acute neuro-cardiovascular diseases i.e. stroke, myocardial infarction, or heart failure OTHER

All patients included and followed within one of the three cohorts studies: LOOP-HF, HIBISCUS-STEMI and HIBISCUS-STROKE who accepted to participate in the study, will be contacted by phone (attempted calls are set to 3 to reach the patient), mail or during a consultation, to answer to a health literacy questionnaire. The patient will participate in the study only once. The estimated duration is therefore estimated at 1 day for each patient and two month for the study. Thanks to the many following periods within the cohorts (6 months, 1 year and 18 month), we will measure health literacy at different times of the care.

Study group

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All HCL patients in the LOOP-HF, HIBISCUS-STEMI and HIBISCUS-STROKE cohorts may be included and will constitute the study population.

You may qualify if:

• Age ≥ 18 years
• Can be reached by phone (telephone numbers will be obtained through cohorts)
• Included in one of the 3 cohorts LOOP-HF (Heart Failure), HIBISCUS (stroke and myocardial infarction) with the following eligibility criteria:
• LOOP-HF
• Patient with congestive heart failure confirmed after at the end of: Hospitalization for congestive cardiac decompensation, Follow-up for stable congestive heart failure in consultation with at least one episode of cardiac decompensation within the year
• New York Heart Association (NYHA) ≥ 2
• Age \> 18 years old
• Signature informed consent
• HIBISCUS-STROKE
• Age \> 18 years old
• Diagnosis of ischemic cerebral infarction confirmed by brain imaging
• Visible proximal occlusion on brain imaging (ACI or M1)
• Patient treated with thrombolysis and/or thrombectomy
• Signature of consent by the patient or family member
• HIBISCUS-STEMI

You may not qualify if:

• Announcing an opposition to the study (an information letter will be sent to patients at home and their non-opposition to the study will be considered if the patient does not contact the coordination centre)
• Not speaking French
• LOOP-HF
• Life expectancy \< 1 year
• Patient over 90 years of age
• Recent discovery of heart failure (\< 3 months) long-term assisted or cardiac transplant patient
• Inability to provide the patient with informed information
• Loss of autonomy, dementia, major dependence
• Lack of coverage by the social security system
• HIBISCUS-STROKE
• Patients \> 50 km from Pierre Wertheimer Hospital (follow-up in Lyon impossible)
• Patient for whom H0 sampling is not possible (telemedicine)
• Patient with active or uncontrolled cancer.
• Stroke of unknown schedule
• Lack of coverage by a Social Security scheme

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

MeSH Terms

Conditions

Cardiovascular Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 14, 2019
• First Posted: May 16, 2019
• Study Start: July 19, 2019
• Primary Completion: December 17, 2020
• Study Completion: December 17, 2020
• Last Updated: August 22, 2022

Record last verified: 2022-08